Page 121 | Certara

On-Demand Webinar

FDA’s Digital Transformation: The Future of Technology and How to Prepare

As Life-Science manufacturers embrace new technologies to speed time to market and products become more…

CertaraOctober 5, 2021

Press Release

Certara Completes Acquisition of Pinnacle 21

PRINCETON, N.J., Oct. 04, 2021 - Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation,…

Simona ColucciOctober 4, 2021

White Paper

Using Real-world Evidence to Advance Market Access for New Therapeutics

CertaraSeptember 29, 2021

Case Study

Organizing Complex Virology Datasets into FDA-Ready Format using SAS Programming

Streamline virology dataset organization with advanced SAS programming.

CertaraSeptember 23, 2021

On-Demand Webinar

The Scary Future of Rare Disease Management

In a world of rising healthcare costs, the greatest nightmare for payers is reimbursing drug…

CertaraSeptember 23, 2021

Publication

Drug repurposing: Misconceptions, challenges, and opportunities for academic researchers

Drug repurposing is promoted as a cost- and time-effective mechanism for providing new medicines. Often,…

CertaraSeptember 23, 2021

On-Demand Webinar

Preparing Vaccine Studies for Regulatory Submissions

In this webinar, Michael Beers reviews FDA, PMDA, and CDISC guidance for preparing vaccine studies…

CertaraSeptember 10, 2021

On-Demand Webinar

SDTM Trial Summary Domain Puzzle: Are These the Right Pieces?

TS can be complex to implement with guidance spread across SDTMIG, FDA Study Data Technical…

CertaraSeptember 10, 2021

Blog

Pediatric Drug Development: Optimizing Extrapolation

Drug development in pediatrics continues to be a substrate for the application of innovative tools…

CertaraSeptember 1, 2021

Case Study

Using Simcyp Simulator to Determine DDI Liability of Guanfacine in Children

Guanfacine (Intuniv® XR) extended release (GXR) is an orally administered, selective alpha2A-adrenergic receptor agonist, non-stimulant…

CertaraAugust 26, 2021

FDA’s Digital Transformation: The Future of Technology and How to Prepare

Certara Completes Acquisition of Pinnacle 21

Using Real-world Evidence to Advance Market Access for New Therapeutics

Organizing Complex Virology Datasets into FDA-Ready Format using SAS Programming

The Scary Future of Rare Disease Management

Drug repurposing: Misconceptions, challenges, and opportunities for academic researchers

Preparing Vaccine Studies for Regulatory Submissions

SDTM Trial Summary Domain Puzzle: Are These the Right Pieces?

Pediatric Drug Development: Optimizing Extrapolation

Using Simcyp Simulator to Determine DDI Liability of Guanfacine in Children

Newsletter sign up

Quick links

Solutions

Contact